Literature DB >> 31666374

Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs.

Weitong Yao1, Takeshi Yoshida2, Saki Hashimoto1, Hiroaki Takeuchi1, Klaus Strebel3, Shoji Yamaoka2.   

Abstract

BST-2/CD317/tetherin is a host transmembrane protein that potently inhibits human immunodeficiency virus type 1 (HIV-1) virion release by tethering the nascent virions to the plasma membrane. Viral protein U (Vpu) is an accessory protein encoded by HIV-1 as well as by some simian immunodeficiency viruses (SIVs) infecting wild chimpanzees, gorillas, or monkeys (SIVcpz, SIVgor, or SIVgsn/SIVmon/SIVmus, respectively). HIV-1 Vpu directly binds to and downregulates human BST-2. The antagonism is highly species specific because the amino acid sequences of BST-2 are different among animal species. Here, we show that Vpu proteins from several SIVcpz, SIVgsn, SIVmon, or SIVmus isolates fail to antagonize human BST-2. Only Vpu from an SIVgsn isolate (SIVgsn-99CM71 [SIVgsn71]) was able to antagonize human BST-2 as well as BST-2 of its natural host, greater spot-nosed monkey (GSN). This SIVgsn Vpu interacted with human BST-2, downregulated cell surface human BST-2 expression, and facilitated HIV-1 virion release in the presence of human BST-2. While the unique 14AxxxxxxxW22 motif in the transmembrane domain of HIV-1NL4-3Vpu was reported to be important for antagonizing human BST-2, we show here that two AxxxxxxxW motifs (A22W30 and A25W33) exist in SIVgsn71 Vpu. Only the A22W30 motif was needed for SIVgsn71 Vpu to antagonize GSN BST-2, suggesting that the mechanism of this antagonism resembles that of HIV-1NL4-3 Vpu against human BST-2. Interestingly, SIVgsn71 Vpu requires two AxxxxxxxW (A22W30 and A25W33) motifs to antagonize human BST-2, suggesting an as-yet-undefined way that SIVgsn71 Vpu works against human BST-2. These results imply an evolutionary impact of primate BST-2 on lentiviral Vpu.IMPORTANCE Genetic alterations conferring a selective advantage in protecting from life-threating pathogens are maintained during evolution. In fact, the amino acid sequences of BST-2 differ among primate animals and their susceptibility to viral proteins is species specific, suggesting that such genetic diversity has arisen through the evolutionarily controlled balance between the host and pathogens. The M (main) group of HIV-1 is thought to be derived from SIVcpz, which utilizes Nef, but not Vpu, to antagonize chimpanzee BST-2. SIVcpz Nef is, however, unable to antagonize human BST-2, and Vpu was consequently chosen again as an antagonist against human BST-2 in the context of HIV-1. Studies on how Vpu lost and acquired this ability, together with the distinct mechanisms by which SIVgsn71 Vpu binds to and downregulates human or GSN BST-2, may help to explain the evolution of this lentiviral protein as a result of host-pathogen interactions.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  BST-2; HIV-1; SIV; SIVgsn; Vpu; accessory protein; interaction; restriction factor; virus release

Mesh:

Substances:

Year:  2020        PMID: 31666374      PMCID: PMC6955256          DOI: 10.1128/JVI.01669-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Chimpanzee reservoirs of pandemic and nonpandemic HIV-1.

Authors:  Brandon F Keele; Fran Van Heuverswyn; Yingying Li; Elizabeth Bailes; Jun Takehisa; Mario L Santiago; Frederic Bibollet-Ruche; Yalu Chen; Louise V Wain; Florian Liegeois; Severin Loul; Eitel Mpoudi Ngole; Yanga Bienvenue; Eric Delaporte; John F Y Brookfield; Paul M Sharp; George M Shaw; Martine Peeters; Beatrice H Hahn
Journal:  Science       Date:  2006-05-25       Impact factor: 47.728

2.  Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides.

Authors:  W P Stemmer; A Crameri; K D Ha; T M Brennan; H L Heyneker
Journal:  Gene       Date:  1995-10-16       Impact factor: 3.688

3.  BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action.

Authors:  Mark Skasko; Andrey Tokarev; Cheng-Chang Chen; Wolfgang B Fischer; Satish K Pillai; John Guatelli
Journal:  Virology       Date:  2011-01-14       Impact factor: 3.616

4.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.

Authors:  F Gao; E Bailes; D L Robertson; Y Chen; C M Rodenburg; S F Michael; L B Cummins; L O Arthur; M Peeters; G M Shaw; P M Sharp; B H Hahn
Journal:  Nature       Date:  1999-02-04       Impact factor: 49.962

5.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

6.  Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny.

Authors:  Valérie Courgnaud; Marco Salemi; Xavier Pourrut; Eitel Mpoudi-Ngole; Bernadette Abela; Philippe Auzel; Frédéric Bibollet-Ruche; Beatrice Hahn; Anne-Mieke Vandamme; Eric Delaporte; Martine Peeters
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Characterization of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona).

Authors:  Katrina L Barlow; Adebowale Oluwafemi Ajao; Jonathan P Clewley
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 8.  HIV accessory proteins versus host restriction factors.

Authors:  Klaus Strebel
Journal:  Curr Opin Virol       Date:  2013-11-15       Impact factor: 7.090

9.  Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells.

Authors:  Tom K Kerppola
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

10.  Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.

Authors:  Ravindra K Gupta; Petra Mlcochova; Annegret Pelchen-Matthews; Sarah J Petit; Giada Mattiuzzo; Deenan Pillay; Yasuhiro Takeuchi; Mark Marsh; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

View more
  1 in total

1.  Simian Immunodeficiency Virus SIVgsn-99CM71 Vpu Employs Different Amino Acids To Antagonize Human and Greater Spot-Nosed Monkey BST-2.

Authors:  Weitong Yao; Klaus Strebel; Shoji Yamaoka; Takeshi Yoshida
Journal:  J Virol       Date:  2021-12-08       Impact factor: 6.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.